Capricor Therapeutics, Inc.

NasdaqCM:CAPR Stock Report

Market Cap: US$176.6m

Capricor Therapeutics, Inc. Company Information

Capricor Therapeutics, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Capricor Therapeutics, Inc.
  • Ticker: CAPR
  • Exchange: NasdaqCM
  • Founded: 2005
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$176.554m
  • Shares Outstanding: 31.81m
  • Website: https://www.capricor.com

Number of Employees


Location

  • Capricor Therapeutics, Inc.
  • 10865 Road to the Cure
  • Suite 150
  • San Diego
  • California
  • 92121
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CAPRNasdaqCM (Nasdaq Capital Market)YesNew Common StockUSUSDNov 2013
4LN2DB (Deutsche Boerse AG)YesNew Common StockDEEURNov 2013

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/06/12 00:00
End of Day Share Price 2024/06/12 00:00
Earnings2024/03/31
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.